Patents by Inventor Martin Fugère

Martin Fugère has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CELL-BASED ASSAY FOR MEASURING DRUG PRODUCT POTENCY
    Publication number: 20210255185
    Abstract: The invention relates to an in vitro quantative cell-based assay that uses a primary mouse cell model system permissive to viral vector infection and a quantitative high content image-based system for determining potency of a transgene-expressing viral vector drug product for lot disposition.
    Type: Application
    Filed: June 7, 2019
    Publication date: August 19, 2021
    Inventors: Brian KASPAR, Allan KASPAR, Kevin FOUST, Martin FUGERE, Eunhye PARK, Gretchen THOMSEN, Fengrong ZUO
  • Multi-leu peptides and analogues thereof as selective PACE4 inhibitors and effective antiproliferative agents
    Patent number: 9573974
    Abstract: Disclosed herein are PACE4 inhibitors, compositions comprising PACE4 inhibitors and their uses thereof for lowering PACE4 activity, reducing cell proliferation, reducing tumor growth, reducing metastasis formation, preventing and/or treating cancer. Also provided are methods for lowering PACE4 activity, reducing the proliferation of a cell, reducing tumor growth and/or treating and preventing cancer. Methods for screening PACE4 inhibitors and cell proliferation inhibitors are further provided.
    Type: Grant
    Filed: January 8, 2014
    Date of Patent: February 21, 2017
    Assignee: LA SOCIETE DE COMMERCIALISATION DES PRODUITS DE LA RECHERCHE APPLIQUEE SOCPRA-SCIENCES SANTE ET HUMAINES S.E.C.
    Inventors: Robert Day, Martin Fugére, Witold A. Neugebauer
  • MULTI-LEU PEPTIDES AND ANALOGUES THEREOF AS SELECTIVE PACE4 INHIBITORS AND EFFECTIVE ANTIPROLIFERATIVE AGENTS
    Publication number: 20140256646
    Abstract: Disclosed herein are PACE4 inhibitors, compositions comprising PACE4 inhibitors and their uses thereof for lowering PACE4 activity, reducing cell proliferation, reducing tumor growth, reducing metastasis formation, preventing and/or treating cancer. Also provided are methods for lowering PACE4 activity, reducing the proliferation of a cell, reducing tumor growth and/or treating and preventing cancer. Methods for screening PACE4 inhibitors and cell proliferation inhibitors are further provided.
    Type: Application
    Filed: January 8, 2014
    Publication date: September 11, 2014
    Applicant: Societe De Commercialisation Des Produits De La Recherche Appliquee Socpra San
    Inventors: Robert Day, Martin Fugére, Witold A. Neugebauer
  • Multi-LEU peptides and analogues thereof as selective PACE4 inhibitors and effective antiproliferative agents
    Patent number: 8658591
    Abstract: Disclosed herein are PACE4 inhibitors, compositions comprising PACE4 inhibitors and their uses thereof for lowering PACE4 activity, reducing cell proliferation, reducing tumor growth, reducing metastasis formation, preventing and/or treating cancer. Also provided are methods for lowering PACE4 activity, reducing the proliferation of a cell, reducing tumor growth and/or treating and preventing cancer. Methods for screening PACE4 inhibitors and cell proliferation inhibitors are further provided.
    Type: Grant
    Filed: July 6, 2009
    Date of Patent: February 25, 2014
    Inventors: Robert Day, Martin Fugère, Witold A. Neugebauer
  • Multi-LEU Peptides and Analogues Thereof as Selective PACE4 Inhibitors and Effective Antiproliferative Agents
    Publication number: 20110178027
    Abstract: Disclosed herein are PACE4 inhibitors, compositions comprising PACE4 inhibitors and their uses thereof for lowering PACE4 activity, reducing cell proliferation, reducing tumor growth, reducing metastasis formation, preventing and/or treating cancer. Also provided are methods for lowering PACE4 activity, reducing the proliferation of a cell, reducing tumor growth and/or treating and preventing cancer. Methods for screening PACE4 inhibitors and cell proliferation inhibitors are further provided.
    Type: Application
    Filed: July 6, 2009
    Publication date: July 21, 2011
    Inventors: Robert Day, Martin Fugère, Witold A. Neuge-Bauer